Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Stockholm: The Presenilin Signaling Hub—A RIP-off or the Real Deal?
1 August 2002. Ever since Cao and Sudhof (Science 2001 293, 115-120) provided the first evidence that the intracellular domain of APP (AICD) translocates to the nucleus and may be involved in transcriptional regulation, there has been a reawakening of interest in APP function. Thus, it was appropriate that one of the most thought provoking presentations of the entire meeting addressed this important issue. Breaking from his published abstract Bruce Yankner (Abstract 1061) spoke to the role of presenilin-mediated regulated intramembrane proteolysis (RIP) in cell signaling.

Using Affymetrix gene chips, Yankner and colleagues compared the transcriptional profile of wild type and PS1/PS2 double knockout embryonic stem (ES) cells. Given the dramatic effect of the PS double knockout, it was perhaps not surprising that the gene expression profile of double KO ES cells was substantially different from wild-type ES cells. Indeed, one percent of the total genes detected were altered in the double knockout ES cells.

Mindful of the burgeoning list of putative γ-secretase substrates (see below) Yankner further refined his analysis to attribute the observed changes to the two best characterized γ-secretase substrates, APP and Notch. Cells were transfected with constructs encoding an AICD-like fragment (the C-terminal 59 amino acids of APP) or NICD, RNA extracted and transcriptional profiles determined as before. Interestingly only seven genes were rescued by AICD: the kinesin receptor, Follistatin, TGFβ induced early growth response, caspase 7, Calbindin, Fragile X, and a novel gene product PRT. Of these the kinesin receptor (see Kamal et al. Nature 2002) and the calcium-binding protein Calbindin are particularly interesting. At the Elan satellite symposium on 22 July, Lennart Mucke also reported that Calbindin was elevated in AβPP transgenic mice. PRT, a novel gene cloned from ESTs with homology to the tetraspanins, was markedly increased in PS double knockout ES cells and elevated in ES cells treated with inhibitors of γ-secretase. The tetraspanins are inhibitors of metasis, involved in cell migration and synapse formation, and tetraspanin Kal1 has been shown to be directly activated by a ternary complex containing AICD (Baek et al. 2002 Cell 110, 55-67).

As one would predict based on knockout models of AβPP and Notch, transfection of ES cells with NICD recovered a substantially larger number of genes than the handful of genes rescued by AICD, with many of the NICD-rescued genes acting to stimulate cell migration. In addition, a third set of genes (including APOE and PrP) were altered in the PS double knockout cells but were not recovered by either AICD or NICD.

Although gene array analysis is still fraught with difficulties, and notwithstanding caveats about certain technical aspects of the reported study, the innovative approach of identifying transcriptional targets by comparison of PS double KO cells with wild type or ICD-rescued cells should aid in the identification of the gene targets regulated by ICDs of the various γ-secretase substrates.-Dominic M. Walsh, Ph.D. (Harvard Institutes of Medicine)

Putative Substrates for PS/γ-secretase

1. Erb4 (Todd Golde #549)

2. LRP*

3. APLP1 and 2*

4. Syndecan 3 (Bart DeStrooper #1043)**

5. CD44 (Kwang-Mook Jung & Tae-Wan Kim #782; Sven Laminch & C. Haass, have detected p3-like peptides #1059)**

6. Notch (Okochi & C. Haass, have detected p3-like peptides, #1059)

7. E-Cadherin (Robakis et al. #2079)

8. Delta/Jagged (Sisodia # 1572; LaVoie & Selkoe abstract# 658)**

9. Nectin 1 (Dora Kovacs #532)**

* These proteins were mentioned as γ -secretase substrates by several speakers but to my knowledge have yet to be confirmed.
** Novel presentation at this meeting.

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad